Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Signal Integration of IFN-I and IFN-II With TLR4 Involves Sequential Recruitment of STAT1-Complexes and NFκB to Enhance Pro-inflammatory Transcription.

Piaszyk-Borychowska A, Széles L, Csermely A, Chiang HC, Wesoły J, Lee CK, Nagy L, Bluyssen HAR.

Front Immunol. 2019 Jun 4;10:1253. doi: 10.3389/fimmu.2019.01253. eCollection 2019.

2.

Phenotypic plasticity of Escherichia coli upon exposure to physical stress induced by ZnO nanorods.

Matuła K, Richter Ł, Janczuk-Richter M, Nogala W, Grzeszkowiak M, Peplińska B, Jurga S, Wyroba E, Suski S, Bilski H, Silesian A, Bluyssen HAR, Derebecka N, Wesoły J, Łoś JM, Łoś M, Decewicz P, Dziewit L, Paczesny J, Hołyst R.

Sci Rep. 2019 Jun 12;9(1):8575. doi: 10.1038/s41598-019-44727-w.

3.

Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease.

Antonczyk A, Krist B, Sajek M, Michalska A, Piaszyk-Borychowska A, Plens-Galaska M, Wesoly J, Bluyssen HAR.

Front Immunol. 2019 May 24;10:1176. doi: 10.3389/fimmu.2019.01176. eCollection 2019.

4.

Transcriptomic Changes in Broiler Chicken Hypothalamus during Growth and Development.

Piórkowska K, Żukowski K, Połtowicz K, Nowak J, Wojtysiak D, Derebecka N, Wesoły J, Ropka-Molik K.

Int J Genomics. 2018 Oct 14;2018:6049469. doi: 10.1155/2018/6049469. eCollection 2018.

5.

Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs.

Plens-Galaska M, Szelag M, Collado A, Marques P, Vallejo S, Ramos-González M, Wesoly J, Sanz MJ, Peiró C, Bluyssen HAR.

Front Immunol. 2018 Sep 19;9:2141. doi: 10.3389/fimmu.2018.02141. eCollection 2018.

6.

Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates.

Pstrąg N, Ziemnicka K, Bluyssen H, Wesoły J.

Mol Cancer. 2018 Aug 8;17(1):116. doi: 10.1186/s12943-018-0866-1. Review.

7.

A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses.

Michalska A, Blaszczyk K, Wesoly J, Bluyssen HAR.

Front Immunol. 2018 May 28;9:1135. doi: 10.3389/fimmu.2018.01135. eCollection 2018. Review.

8.

Examining the Genetic Background of Porcine Muscle Growth and Development Based on Transcriptome and miRNAome Data.

Ropka-Molik K, Pawlina-Tyszko K, Żukowski K, Piórkowska K, Żak G, Gurgul A, Derebecka N, Wesoły J.

Int J Mol Sci. 2018 Apr 16;19(4). pii: E1208. doi: 10.3390/ijms19041208.

9.

Potential protective role of Grainyhead-like genes in the development of clear cell renal cell carcinoma.

Pawlak M, Kikulska A, Wrzesinski T, Rausch T, Kwias Z, Wilczynski B, Benes V, Wesoly J, Wilanowski T.

Mol Carcinog. 2017 Nov;56(11):2414-2423. doi: 10.1002/mc.22682. Epub 2017 Jun 15.

PMID:
28543713
10.

Mutations in proteasome-related genes are associated with thyroid hemiagenesis.

Budny B, Szczepanek-Parulska E, Zemojtel T, Szaflarski W, Rydzanicz M, Wesoly J, Handschuh L, Wolinski K, Piatek K, Niedziela M, Ziemnicka K, Figlerowicz M, Zabel M, Ruchala M.

Endocrine. 2017 May;56(2):279-285. doi: 10.1007/s12020-017-1287-4. Epub 2017 Apr 7.

11.

Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA.

Kluzek K, Srebniak MI, Majer W, Ida A, Milecki T, Huminska K, van der Helm RM, Silesian A, Wrzesinski TM, Wojciechowicz J, Beverloo BH, Kwias Z, Bluyssen HAR, Wesoly J.

Oncotarget. 2017 Apr 25;8(17):28558-28574. doi: 10.18632/oncotarget.15331.

12.

Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease.

Szelag M, Piaszyk-Borychowska A, Plens-Galaska M, Wesoly J, Bluyssen HA.

Oncotarget. 2016 Jul 26;7(30):48788-48812. doi: 10.18632/oncotarget.9195. Review.

13.

The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses.

Blaszczyk K, Nowicka H, Kostyrko K, Antonczyk A, Wesoly J, Bluyssen HA.

Cytokine Growth Factor Rev. 2016 Jun;29:71-81. doi: 10.1016/j.cytogfr.2016.02.010. Epub 2016 Mar 18. Review.

14.

STAT1 and IRF8 in Vascular Inflammation and Cardiovascular Disease: Diagnostic and Therapeutic Potential.

Chmielewski S, Piaszyk-Borychowska A, Wesoly J, Bluyssen HA.

Int Rev Immunol. 2016 Sep 2;35(5):434-454. Epub 2015 Nov 25. Review.

PMID:
26606328
15.

Advances in peptidic and peptidomimetic-based approaches to inhibit STAT signaling in human diseases.

Szelag M, Wesoly J, Bluyssen HA.

Curr Protein Pept Sci. 2016;17(2):135-46. Review.

PMID:
26521960
16.

Potential Approaches and Recent Advances in Biomarker Discovery in Clear-Cell Renal Cell Carcinoma.

Majer W, Kluzek K, Bluyssen H, Wesoły J.

J Cancer. 2015 Sep 5;6(11):1105-13. doi: 10.7150/jca.12145. eCollection 2015. Review.

17.

Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors.

Wrzesiński T, Szelag M, Cieślikowski WA, Ida A, Giles R, Zodro E, Szumska J, Poźniak J, Kwias Z, Bluyssen HA, Wesoly J.

BMC Cancer. 2015 Jul 14;15:518. doi: 10.1186/s12885-015-1530-4.

18.

Consequences of the loss of the Grainyhead-like 1 gene for renal gene expression, regulation of blood pressure and heart rate in a mouse model.

Pawlak M, Walkowska A, Mlącki M, Pistolic J, Wrzesiński T, Benes V, Jane SM, Wesoły J, Kompanowska-Jezierska E, Wilanowski T.

Acta Biochim Pol. 2015;62(2):287-96. doi: 10.18388/abp.2015_1001. Epub 2015 Apr 21.

19.

Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.

Szelag M, Czerwoniec A, Wesoly J, Bluyssen HA.

PLoS One. 2015 Feb 24;10(2):e0116688. doi: 10.1371/journal.pone.0116688. eCollection 2015.

20.

STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1.

Blaszczyk K, Olejnik A, Nowicka H, Ozgyin L, Chen YL, Chmielewski S, Kostyrko K, Wesoly J, Balint BL, Lee CK, Bluyssen HA.

Biochem J. 2015 Mar 15;466(3):511-24. doi: 10.1042/BJ20140644.

Supplemental Content

Loading ...
Support Center